Carlyle and the other shareholders of Tescan have entered into a definitive agreement with Shimadzu Corporation for the sale of the company, marking a change in Tescan’s shareholding structure.
This is an important moment for Tescan and reflects the strength of the company’s expertise, teams, and global impact. The transaction is subject to customary closing conditions and regulatory approvals.
Complementary strengths
Shimadzu is a global leader in analytical and measuring technologies. Tescan brings advanced microscopy, micro-CT, laser solutions and focused beam innovation, serving customers across material sciences, life sciences, geo sciences and the semiconductor industry. The portfolios of the two companies complement each other in both technology and market focus.
People remain at the core of Tescan
The agreement recognizes the value of Tescan’s people and their expertise. Tescan’s product innovation, applications knowledge, and scientific insight will continue to drive the company’s direction.
What happens now
There is no change to customer relationships, service support, warranties, or ongoing projects. Tescan continues to operate independently until the transaction closes.
The official Carlyle announcement can be found HERE.
